Psoralen
- Generic Name
- Psoralen
- Drug Type
- Small Molecule
- Chemical Formula
- C11H6O3
- CAS Number
- 66-97-7
- Unique Ingredient Identifier
- KTZ7ZCN2EX
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Phase 1
Completed
- Conditions
- LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
- Interventions
- Procedure: Allogeneic bone marrow transplantationProcedure: In vitro-treated peripheral blood stem cell transplantation (PBSCT)Radiation: Radiation Therapy (RT)
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT00005092
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Washington University Barnard Cancer Center, Saint Louis, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath